Bio-Matrix Announces Installation of New 2000 L Perma-Cyl Liquid Nitrogen Tank for Stem Cell Cryogenisis.SAN DIEGO -- Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXP BMXP Boston Metropolitan Exchange Point ), a biotechnology company focused on stem cell cryogenics cryogenics: see low-temperature physics. cryogenics Study and use of low-temperature phenomena. The cryogenic temperature range is from −238°F (−150°C) to absolute zero. At low temperatures, matter has unusual properties. and disposable stem cell / tissue transfer instruments, (http://www.bmxgonline.com), announced today that a new 2000 L Perma-Cyl Liquid Nitrogen tank has been installed by Correct Cryogenics Inc. at Bio-Matrix' Stem Bank and Laboratories facility. The 2000 L Perma-Cyl nitrogen tank is an innovative design evolving from proven technology that has been used in liquid cylinders for years. The 10 ft x 4 ft tank weighs 3,860 lbs and will hold 2,042 liters of liquid nitrogen. The new 2000 L Perma-Cyl features all stainless steel construction; patented float shutoff shut·off n. 1. A device that shuts something off. 2. A stoppage; a cessation. device; remote filling direct to Perma-Cyl or though piping from wall box; and easy-to-read digital Cyl-Tel gauges. The revolutionary 2000 L Perma-Cyl tank has fast fill capability on-site, no-loss fill with automatic fill termination, extended hold time and a telemetry capability with 120V power and non-dedicated phone lines. Bio-Matrix purchased the 2000 L Perma-Cyl tank from Airgas Inc., a bulk gas specialist. Airgas, Inc. (NYSE NYSE See: New York Stock Exchange :ARG See argument. arg - argument ), through its subsidiaries, is the largest U.S. distributor of industrial, medical, and specialty gases. Airgas is also the third largest U.S. distributor of safety products, the largest U.S. producer of nitrous oxide and dry ice, the largest liquid carbon dioxide producer in the Southeast, and a leading distributor of process chemicals, refrigerants Chemical refrigerants are assigned an R number(sometimes the label replaces it with the word Freon) which is determined systematically according to molecular structure. The following is a list of refrigerants with their R numbers, IUPAC chemical name, molecular formula, and CAS number. and ammonia products. Its 10,000 employees work in about 900 locations including branches, gas fill plants, specialty gas labs, production facilities and distribution centers. This press release is available on the company's official online Investor Relations HUB at http://www.agoracom.com/IR/Bio-Matrix for investor questions, answers and monitored commentary. Alternatively, investors are able to e-mail all questions and correspondence to BMXP@agoracom.com where they can also request addition to the investor e-mail list to receive all future press releases and updates in real time. About Bio-Matrix Scientific Group Inc. Bio-Matrix Scientific Group Inc. is a development stage company in the business of medical devices and monitoring systems research, development and commercialization. Bio-Matrix Scientific Group Inc. is aligning itself with partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems. Other companies in the same industry as Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXP) are Cord Blood America (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CBAI CBAI The Community Bankers Association of Illinois CBAI Contract Bridge Association of Ireland (UK) ), StemCells Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :STEM) and Regeneration Technologies (OTCBB:RTIX). More information will be available shortly on the Company's website: www.BMXGonline.com DISCLAIMER: This news release contains forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion